2 0 1 a r t I C l e S Voltage-gated calcium channels (VGCCs) such as Ca V 1.2 are essential for coupling electrical events to the activation of intracellular signaling pathways that control the development and function of neurons 1 . Mutations in VGCC genes have been linked to various neurological and psychiatric disorders, including epilepsy, ataxia, migraine, ASDs and schizophrenia [2] [3] [4] [5] [6] . Although a great deal is understood about how disease-causing mutations change the biophysical properties of these channels 7, 8 , little is known about how these mutations alter neuronal development and cause disease. Unraveling this relationship is critical for understanding how mutations in VGCCs ultimately lead to neuronal dysfunction and regulate neuronal signaling under nonpathological conditions. L-type voltage-gated calcium channels (LTCs) are characterized by their large single-channel conductance, activation at depolarized potentials and sensitivity to dihydropyridines 9 . The α1 subunit of the channel contains the voltage sensor and ion pore, and forms a complex with β and α2δ subunits that regulate channel trafficking and gating 9,10 . Ca V 1.2 is the most abundant of the three LTCs in the mammalian brain and is expressed on the cell body, dendrites and growth cones of developing neurons 11, 12 . Timothy syndrome is a multisystem disorder characterized by cardiac arrhythmias, webbing of the fingers and toes, hypoglycemia and autism 13 . It is caused by a dominant mutation in an alternatively spliced exon of the CACNA1C gene, which encodes the α subunit of the L-type VGCC, Ca V 1.2 (ref. 13). The mutation that causes Timothy syndrome results in a glycinefor-arginine substitution at position 406 in the first of three intracellular loops in Ca V 1.2 that alters the ability of Ca V 1.2 to undergo voltage-dependent and calcium-dependent inactivation. This mutation thus presents an excellent opportunity to examine the importance of these processes in neuronal development and function.
A major function of Ca V 1.2 is to regulate dendritic refinement in response to electrical activity [14] [15] [16] . Dendritic arbors are essential for the processing of information by neurons and have a key role in the formation of the neuronal circuits that underlie cognition 16 . Precisely how LTCs regulate dendritic development is not well understood. Although LTCs can activate transcription factors such as CREB and CREST that control the expression of genes involved in dendritic arborization 15, 17 , there is considerable evidence that activity-dependent arborization also involves local activation of signaling pathways in dendrites [18] [19] [20] . The RGK (Rad, Rem, Rem2 and Gem/Kir) family of small GTP-binding proteins provides a potential link between Ca V 1.2 channels and dendritic arborization. Gem and Rem2 are both expressed in neurons 21, 22 and bind to the β subunit of voltage-gated Ca 2+ channels 23, 24 . The function of RGK proteins in neurons is not well understood, but they have been shown to regulate channel function both by altering channel trafficking [24] [25] [26] and by directly reducing channel activity 23, 27 . The RGK proteins have also been reported to regulate signaling proteins that control dendritic arbors such as Rho-GAP, Gem interacting protein (GMIP) 28 and the Rho kinase ROK1 (ref. 29) . Whether the RGK proteins connect voltage-gated Ca 2+ channels to the signaling pathways that regulate dendritic morphology is not known.
In this study, we used animal and human models of Timothy syndrome to study the effects of the mutation that causes Timothy syndrome on dendritic arbors both in vitro and in vivo. In vitro we found that expression of Ca V 1.2 channels with the mutation that causes Timothy syndrome triggered dendrite retraction when these neurons were stimulated electrically, either by bath depolarization or by activation of channelrhodopsin-2. In vivo, we observed changes in the dendritic arbor of neurons in a knock-in mouse model of Timothy a r t I C l e S syndrome. To show that the defects observed in mouse and rat neurons also occur in humans with Timothy syndrome, we generated iPSC-derived neurons from individuals with Timothy syndrome and found that these cells also exhibited activity-dependent dendrite retraction. In studying the mechanism underlying these defects, we discovered that dendrite retraction triggered by the mutation that causes Timothy syndrome was independent of Ca 2+ flux through the channel. Instead, conformational changes in the Ca V 1.2 channel activated RhoA signaling via the small G protein Gem, leading to dendrite retraction in response to electrical activity. These results identify a new mechanism by which Ca V 1.2 can regulate signaling cascades in neurons and provide important insights into the pathophysiology of Timothy syndrome and other ASDs.
RESULTS

Dendrite retraction in rat neurons
Although voltage-gated calcium channels are known to have a key role in dendrite growth in many systems, their importance in regulating dendrite development in cortical neurons has not been established. We first investigated which types of channels are important for controlling dendritic arbors in developing cortical neurons and found that blockers of LTCs completely eliminated dendrite growth in response to depolarization, whereas other channel blockers had no significant effect (P > 0.05; Supplementary Figs. 
1,2a-d).
To investigate the effects of the mutation that causes Timothy syndrome on activitydependent arborization, we introduced plasmids encoding wild-type Ca V 1.2 channels or Ca V 1.2 channels with the mutation (G406R) that causes Timothy syndrome (here called TS-Ca V 1.2 channels) together with YFP into rat cortical neurons. Using anti-Ca V 1.2 antibodies we found that expression of wild-type Ca V 1.2 and TS-Ca V 1.2 channels was similar to that of the endogenous channel, and that both channels were localized at the cell membrane ( Supplementary Figs. 2e-f,3) . Then using fluorescence microscopy we measured changes in the dendritic arbor of individual cells over 9 h. We observed no differences in the length of the dendritic arbors in resting neurons expressing wild-type Ca V 1.2 or TS-Ca V 1.2 channels. However, activation of LTCs by depolarization caused a pronounced increase in the length and complexity of the dendritic arbor in neurons expressing wildtype channels (Fig. 1a,b) . In contrast, depolarization caused a dramatic reduction in dendrite length in neurons containing TS-Ca V 1.2. This retraction was not due to an increase in apoptosis or necrosis, as we did not observe any differences in terminal deoxynucleotide transferase (TdT)-mediated dUTP-digoxigenin nick-end labeling (TUNEL) or nuclear condensation between TS-Ca V 1.2-expressing and control neurons (Supplementary Fig. 3 ).
Dendrite growth is the sum of dynamic extension and retraction events over the course of minutes and hours, and changes in either the number of extension or retraction events or in the amplitude of each event can lead to changes in the total dendrite length. To determine whether the TS-Ca V 1.2 channel affects either the number or length of dendritic retraction or extension events, we used high-frequency time-lapse imaging to capture these events over 1 h. Dendrites from neurons expressing wild-type Ca V 1.2 underwent slightly more extension than retraction events, leading to a net growth of the dendritic arbor. In contrast, neurons expressing TS-Ca V 1.2 exhibited an increase in the number of dendritic retraction events and a decrease in the number of extension events, resulting in an overall decrease in dendrite length (Fig. 1c,d ). There was a r t I C l e S no difference in the amplitude of individual retraction or extension events between cells expressing TS-Ca V 1.2 or wild-type Ca V 1.2 ( Supplementary Fig. 4 ), suggesting that activation of TS-Ca V 1.2 caused dendrite retraction by increasing the frequency of retraction events and not the amplitude of each event.
Although membrane depolarization is a robust way of activating LTCs in culture, it is not a physiological stimulus for most neurons. To mimic physiological activation, we introduced channelrhodopsin-2 into rat neurons expressing TS-Ca V 1.2 or wild-type Ca V 1.2 and electrically activated the cells by illuminating them with blue light. Patchclamp recordings showed that neurons fired high-frequency bursts of action potentials for the duration of the illumination (Fig. 1e) . We stimulated the cells to generate four 1-s bursts of action potentials every 30 min over 12 h and collected time-lapse images of the dendritic arbor every 30 min (Fig. 1f ) . Cells expressing TS-Ca V 1.2 showed a significant decrease (P < 0.001) in dendritic outgrowth when compared to cells expressing the wild-type channel (Fig. 1g) , confirming that TS-Ca V 1.2 caused dendrite retraction when neurons were stimulated with physiological patterns of electrical activity.
Dendritic development defects in mice with Timothy syndrome
To study the consequences of the mutation that causes Timothy syndrome on neuronal development in vivo, we generated a mouse model of Timothy syndrome 30 . Using homologous recombination, we introduced a cassette containing a mutation in exon 8 of the mouse gene encoding Ca V 1.2 with the G406R substitution. Mutations in the homologous exon in humans cause type-2 Timothy syndrome. Breeding mice containing this cassette produced only mice heterozygous for the Cacna1c tm2Itl allele, suggesting that this mutation is homozygous lethal in mice, as it is in humans. There was no reduction in the size or viability of heterozygous Cacna1c +/ tm2Itl mice compared to their wild-type littermates, and their gross brain size and structure appeared normal 30 .
We compared the basal dendritic arbors of layer 2/3 pyramidal neurons from matched regions of the frontal cortex of wild-type and Cacna1c +/ tm2Itl littermates using Golgi staining. At postnatal day 7 (P7) we observed no significant difference (P < 0.05) in the total length or number of basal dendrites, suggesting that there were no gross defects in early dendritic development. By postnatal day 14 (P14), however, we observed a significant decrease (P < 0.001) in the total basal dendritic length and in the number of dendritic branches in neurons from Cacna1c +/ tm2Itl mice relative to their wild-type littermates (Fig. 2) . In addition, the Cacna1c +/ tm2Itl mice had approximately six times more neurons with arbors smaller than 600 µM than their wild-type littermates, and approximately one-quarter as many neurons with arbors that exceeded 1,800 µM (Fig. 2h) . The number of primary dendrites in neurons from Cacna1c +/ tm2Itl mice was also slightly decreased relative to controls, although this difference was not significant (P > 0.05; Fig. 2g ). These findings suggest that the mutation that causes Timothy syndrome has a dramatic effect on dendritic arborization at P14 and causes a net reduction in the basal dendritic complexity of cortical pyramidal neurons.
Dendrite retraction in human neurons with Timothy syndrome Recent advances in somatic cell reprogramming 31 allow the study of human neurons differentiated in vitro from individuals with genetic neurodevelopmental diseases 32 . To determine whether the defects observed in mice and rat neurons are also present in humans, we collected dermal fibroblasts from two individuals with Timothy syndrome and generated iPSC lines by infection with retroviruses containing genes encoding SOX2, OCT3/4, Klf4 and c-Myc 33 . We differentiated the cells from individuals with Timothy syndrome and control iPSC clones into cortical neurons using a four-stage protocol as previously described 34 (Fig. 3a) . To measure dendrite development in human neurons, we infected the cells with an adeno-associated virus (AAV5) expressing YFP driven by the human synapsin-1 promoter. We then monitored changes in dendrite length in response to depolarization using time-lapse microscopy ( Fig. 3b) . Neurons derived from Timothy syndrome and control subjects showed similar changes in dendritic length at rest (average change in total dendritic lengths during 30 min of incubation in a 5 mM KCl solution was, for Timothy syndrome samples, 3.67% ± 3.39% and for control, 5.62% ± 2.45%; unpaired Student t-test, P > 0.05, mean ± s.e.m.), but depolarization led to a significant decrease (P < 0.005) in dendritic length in Timothy syndrome-affected neurons but caused dendrite growth in control neurons (Fig. 3c-e) . Depolarization caused an increase npg a r t I C l e S in the number of retraction events and a decrease in the number of extension events (Fig. 3f) , as observed in rat neurons ( Supplementary  Fig. 4b ). These results suggest that human neurons derived from individuals with Timothy syndrome retract their dendrites in response to depolarization and therefore replicate the activity-dependent dendritic retraction observed in rat and mouse neurons with the mutation that causes Timothy syndrome.
Timothy syndrome-induced retraction is Ca 2+ -independent We next determined whether excess Ca 2+ influx through TS-Ca V 1.2 causes dendrite retraction. We measured calcium currents and calcium elevations in neurons expressing TS-Ca V 1.2 and wild-type channels. As previously reported 7, 13, 35 , we found that the mutation that causes Timothy syndrome decreased voltage-dependent inactivation of the channel and increased the Ca 2+ rise triggered by depolarization of the neurons (Fig. 4a,b) . To confirm that this increase depended on Ca 2+ entering through TS-Ca V 1.2, we transfected neurons with wild-type or TS-Ca V 1.2 channels containing a T1036Y mutation, which renders the channels resistant to dihydropyridines such as nimodipine 36 (Fig. 4c) . Although both manipulations increased [Ca 2+ ] i to levels similar to those in neurons affected by Timothy syndrome, neither caused dendrite retraction (Fig. 4d) Fig. 4e ) but did not prevent dendritic retraction after depolarization (Fig. 4f) . In fact, we observed dendritic retraction in neurons affected by Timothy syndrome even in the nominal absence of extracellular Ca 2+ , strongly suggesting that Ca 2+ influx is not required for this process.
Because altering extracellular Ca 2+ can affect neuronal signaling in unexpected ways, we tested whether Ca 2+ influx was required for npg a r t I C l e S activity-dependent dendrite retraction in neurons affected by Timothy syndrome using an independent method. We introduced three glutamate-to-glutamine mutations (E363Q, E706Q and E1115Q) in the selectivity filter of TS-Ca V 1.2 that prevent calcium influx through the channel (here called TS-Ca V 1.2 '3EQ') 37, 38 and expressed these channels in rat neurons. Whole-cell patch clamping confirmed that these channels did not carry any inward calcium or barium currents in cells or cause any measurable increase in [Ca 2+ ] i upon depolarization (Fig. 4g,h ). Upon depolarization, however, calcium-impermeant TS-Ca V 1.2 still caused dendrite retraction (Fig. 4i,j) . We did not observe dendrite retraction in wild-type channels containing the 3EQ mutations, indicating that increased retraction was not a consequence of introducing nonconducting channels into cells. We observed similar results using channels containing four glutamate-to-glutamine mutations (E363Q, E706Q, E1115Q and E1416Q) in the selectivity filter ('4EQ'; Supplementary  Fig. 6 ). Together these results indicate that TS-Ca V 1.2 caused dendrite retraction independently of its capacity to carry calcium.
Gem is required for activity-dependent dendritic extension
One hypothesis to explain these findings is that voltage-dependent conformational changes in TS-Ca V 1.2 activate signaling cascades that promote retraction of dendrites in neurons affected by Timothy syndrome. To identify these pathways, we investigated channelinteracting proteins that could be linked to signaling cascades known to alter the cytoskeleton. The RGK proteins are small G proteins that can regulate RhoA signaling and bind to the β subunit of calcium channels [24] [25] [26] 28, 29 . The β subunit binds to a domain of the α 1 subunit that is immediately downstream of the substitution that causes Timothy syndrome in Ca v 1.2. We therefore explored whether these proteins could be important for Timothy syndrome-dependent dendrite retraction. We first used reverse-transcription (RT)-PCR to determine which transcripts encoding RGK proteins are expressed in cortical neurons, and found transcripts encoding both Gem and Rem2 expressed in these cells (Supplementary Fig. 7a ). We next investigated whether either Rem2 or Gem are necessary for activity-dependent npg a r t I C l e S dendritic arborization by using short hairpin (sh)RNAs to reduce the expression of each protein in developing neurons. We generated three shRNAs to Rem2 and Gem and verified by western blotting that these shRNAs reduced the expression of Rem2 or Gem proteins ( Supplementary Fig. 7b-e) . Reducing Rem2 expression had no effect on activity-dependent dendritic growth (Fig. 5a ), but reducing Gem expression prevented activity-dependent dendritic arborization in a manner that was consistent with the effectiveness of each shRNA Myc-Gem or Myc-Gem-R (which contains silent mutations that render it resistant to Gem shRNA #2) and either control shRNA or Gem shRNA #2. Cells were also transfected with a construct encoding Myc-CFP as a transfection and loading control. Full-length blots are presented in Supplementary Figure 10 .
(e) Average change in total dendrite length in neurons co-transfected with control shRNA or Gem shRNA #2 and constructs expressing either CFP, Gem, or the shRNA-resistant Gem-R. The amount of activity-dependent dendritic arborization in neurons transfected with Gem-R and Gem shRNA #2 is not significantly different from that in cells expressing control shRNA (Gem-R + control shRNA = 168.9 ± 23.9 µm; Gem-R + shRNA #2 = 141.6 ± 23.8 µm). (n ≥ 20 cells per condition; mean ± s.e.m.; *P < 0.05, **P < 0.001 by two-way ANOVA, Bonferroni post-test). a r t I C l e S (Fig. 5b,c) . Inhibition of activity-dependent dendritic arborization by Gem shRNA #2 was specific because expression of a mutant Gem that is resistant to the shRNA could reverse this effect (Fig. 5d,e) . These results suggest that Gem is necessary for activity-dependent dendritic growth in cortical neurons. We next asked whether Gem overexpression could prevent TS-Ca V 1.2-mediated dendrite retraction. We introduced a Gem expression plasmid into wild-type or TS-Ca V 1.2-expressing neurons and measured dendritic arborization. We found that exogenous expression of Gem had no effect on dendritic arborization in wild-type neurons but completely prevented dendritic retraction in TS-Ca V 1.2-expressing neurons (Fig. 6a) . Gem overexpression also prevented dendritic retraction triggered by the TS-Ca V 1.2 4EQ channel, which contains pore mutations that prevent Ca 2+ influx (Fig. 6b) . This suggests that the ability of Gem to rescue TS-Ca V 1.2-mediated dendritic retraction was independent of the effects of Gem on intracellular Ca 2+ levels.
Overexpression of Gem has been found to inhibit RhoA signaling and induce neurite outgrowth in several cell lines 26, 28, 29 . To determine whether Gem acts as a global inhibitor of RhoA in neurons or whether its activity is dependent on a direct interaction with Ca V 1.2, we generated Gem mutants that do not bind to the β subunit 25 . Gem mutants bearing either an R196A or V223A mutation no longer immunoprecipitated with the β subunit (Fig. 6c) but preserved their ability to increase neurite extension in a neuroblastoma cell line, suggesting that they can still inhibit RhoA (Supplementary Fig. 8) . We expressed the Gem R196A or V223A mutants in TS-Ca V 1.2-expressing neurons and measured dendritic retraction upon depolarization. Overexpression of either Gem mutant did not prevent TS-Ca V 1.2-mediated dendritic retraction (Fig. 6d) . This suggests that interaction between the β subunit and Gem is required for Gem to prevent the dendritic retraction caused by TS-Ca V 1.2.
Gem also has been shown to inhibit Ca V 1.2 activity by interfering with the trafficking of the channel to the cell membrane 24 . We therefore explored the hypothesis that Gem expression prevented retraction by reducing the membrane expression of TS-Ca V 1.2. We transfected neurons with constructs encoding either wild-type or TS-Ca V 1.2 channels bearing an intracellular YFP tag and an extracellular HA epitope tag (YH-Ca V 1.2), and measured the amount of HA immunofluorescence in unpermeabilized cells. Overexpression of Gem had no effect on the cell-surface localization of wild-type or TS-YH-Ca V 1.2 channels relative to overexpression of CFP, suggesting that Gem overexpression did not significantly alter Ca V 1.2 membrane localization in cortical neurons (Supplementary Fig. 9 ).
Because loss of Gem caused dendrite retraction in wild-type neurons and overexpression of Gem reversed TS-Ca V 1.2-mediated retraction, we explored the hypothesis that TS-Ca V 1.2 channels may be less effective than wild-type channels at binding Gem. We performed coimmunoprecipitation experiments in lysates from neuroblastoma cells overexpressing a YFP-tagged wild-type Ca V 1.2 or TS-Ca V 1.2 α subunit, an HA-β3 subunit and Flag-Myc-Gem. Both wild-type Ca V 1.2 and TS-Ca V 1.2 α subunits immunoprecipitated with Flag-Myc-Gem, but Gem immunoprecipitated together with about half the amount of TSCa V 1.2 than wild-type Ca V 1.2 did (Fig. 6d-f ). These results suggest that TS-Ca V 1.2 is less efficient at binding Gem compared to wild-type channels and support the hypothesis that TS-Ca V 1.2 channels cause dendrite retraction by failing to interact with Gem. Taken together, these results provide strong evidence that the interaction of Ca V 1.2 with Gem is important for the ability of the channel to control activity-dependent dendritic arborization. 
npg a r t I C l e S
RhoA activation is necessary for TS-Ca V 1.2-dependent retraction A possible downstream target of TS-Ca V 1.2 channels is the GTPase RhoA, which mediates dendrite retraction in many cell types and genetic systems [39] [40] [41] . We therefore investigated whether activation of TS-Ca V 1.2 activates RhoA in cortical neurons. We measured Ser19 phosphorylation of myosin light chain 2 (MLC2), a biochemical event that is downstream of RhoA activation 42 . Under control conditions, cells expressing wild-type Ca V 1.2 or TS-Ca V 1.2 showed low levels of phosphorylated MLC2. After depolarization, TS-Ca V 1.2-expressing neurons exhibited significantly greater levels of phospho-MLC2 than wild-type cells did (P < 0.01; Fig. 7a,b) . This indicates that activation of the TS-Ca V 1.2 channel leads to upregulation of RhoA signaling.
To determine whether TS-Ca V 1.2 activation depends on Ca 2+ influx, we investigated whether the TS-Ca V 1.2 3EQ channel could increase phospho-MLC2 levels after depolarization. We found that TS-Ca V 1.2 3EQ channels significantly increased phospho-MLC2 levels (P < 0.05; Fig. 7c ) indicating that activation of RhoA was Ca 2+ -independent. We next investigated whether activation of RhoA in wild-type neurons can phenocopy the effects of TS-Ca V 1.2. We found that expression of a constitutively active form of RhoA (RhoV14) is sufficient to cause dendritic retraction (Fig. 7d) . To determine whether activation of RhoA is necessary to cause dendrite retraction in TSCa V 1.2-expressing neurons, we inhibited RhoA activation either by expression of a dominant negative form of RhoA (RhoN19; Fig. 7e ) or application of a cell-permeant RhoA inhibitor (C3 transferase; Fig. 7f ). Both RhoN19 expression and treatment with C3 transferase prevented activity-dependent retraction, suggesting that this pathway is required for the effects of the channel. Finally, we investigated whether exogenous expression of Gem prevents RhoA activation in neurons affected by Timothy syndrome (Fig. 7g,h) . We expressed Gem in neurons expressing TS-Ca V 1.2 and found significantly decreased levels of phospho-MLC2 in these cells (P < 0.05), which suggested that Gem prevents ectopic activation of RhoA by TS-Ca V 1.2. Taken together, these studies support a model by which a conformational change in the TS-Ca V 1.2 reduces recruitment of Gem, leading to ectopic activation of RhoA. RhoA in turn activates biochemical cascades that result in dendrite pruning and retraction.
DISCUSSION
The mutation that causes Timothy syndrome leads to decreased calcium-and voltage-dependent inactivation of the Ca V 1.2 channel, but the cellular consequences of this defect are not well understood. Here we showed that TS-Ca V 1.2 channels caused activity-dependent dendrite retraction in rat, mouse and human neurons. This retraction did not depend on excessive Ca 2+ influx through TS-Ca V 1.2 but was mediated by a Ca 2+ -independent mechanism. Our studies are consistent with a model in which activated Ca V 1.2 channels recruit Gem and thereby prevent activation of RhoA, allowing dendrite retraction. TSCa V 1.2 that cannot recruit adequate levels of Gem, leading to ectopic activation of RhoA and dendrite retraction.
These studies provide insights into the pathophysiology of Timothy syndrome and other ASDs. Studies of brains from individuals with ASDs and intellectual disability suggest that impaired dendrite formation is a common feature of many neurodevelopmental disorders. Impaired minicolumn formation has been observed in postmortem brains of individuals with ASDs 43 , and it has been suggested that individuals with autism have changes in long-range and short-range neural connections 44, 45 . Furthermore, several studies have identified defects in dendritic arborization in mouse models of disorders such as Rett syndrome and Fragile X syndrome 46, 47 . Our data uncovered a direct cellular link between the mutation that causes Timothy syndrome in LTCs and defects in dendritic remodeling, and could shed light on the role of arborization defects in other developmental disorders.
We also observed activity-dependent dendritic retraction in human neurons derived from individuals with Timothy syndrome. Although many studies in rat and mouse models of ASD have been informative, there are examples where defects in such models could not be confirmed in humans. Our study showed that dendrite retraction occurs in rat, mouse and human neurons. This provides strong evidence that dendrite retraction is a feature of Timothy syndrome and shows that iPSC-derived neurons can recapitulate defects observed in neurons in vivo.
Our study also provides tantalizing information about the mechanism by which TS-Ca V 1.2 causes dendrite retraction. We found that dendritic retraction was independent of the amount of Ca 2+ flux through the channel. This result was unexpected because changes in [Ca 2+ ] i are thought to be central to LTC-mediated signal transduction in neurons. We have three lines of evidence that support this conclusion. First, elevating [Ca 2+ ] i in wild-type neurons to the same levels observed in Timothy syndrome neurons did not trigger dendrite retraction. Second, reducing extracellular Ca 2+ in neurons affected by Timothy syndrome, even to resting levels, did not prevent activitydependent retraction. Finally, introducing substitutions in TS-Ca V 1.2 that prevent Ca 2+ flux through the channel does not prevent the channel from triggering retraction. These results are consistent with the idea that Ca V 1.2 channels can activate signaling cascades by voltagedependent conformational changes 48, 49 , reminiscent of the physical mechanism by which a related channel Ca V 1.1 causes excitationcontraction coupling in skeletal muscle 50 .
A possible link between conformational changes in Ca V 1.2 and activation of RhoA is the RGK protein Gem. Gem directly binds to both the α and β subunits of Ca V 1.2 channels and can modulate channel gating. We found that Gem overexpression prevented dendritic retraction triggered by TS-Ca V 1.2 and this effect depended on the ability of Gem to bind to the channel. Gem was also required for dendritic arborization in control cells because reduction of Gem with shRNAs prevented activity-dependent dendrite growth. The mechanism by which Gem controls dendrite growth in response to LTCs activation is unclear. One possibility is that activated Ca V 1.2 recruits Gem, which in turn causes local inhibition of RhoA, preventing dendrite retraction and allowing dendrite extension. Gem and the other RGK proteins inhibit RhoA signaling by activating RhoA GAPs and by inhibiting the downstream kinase ROCK. By binding weakly to Gem, TS-Ca V 1.2 does not suppress RhoA activation and leads to dendrite retraction, which dominates over dendrite extension.
Another possibility is that Gem prevents retraction by forcing TS-Ca V 1.2 into an inactivated state where it no longer activates RhoA. This is consistent with the finding that Gem overexpression decreased LTC activity and Ca 2+ influx in neurons by increasing the fraction of Ca V 1.2 channels in a nonconducting state. Despite its negative effects on Ca 2+ influx, Gem expression was required for activity-dependent dendritic arborization, and Gem overexpression did not inhibit dendrite growth. This suggests that Gem is necessary for activating the signaling cascades that promote dendrite extension despite reduced Ca 2+ influx across the membrane.
In summary, our studies showed that TS-Ca V 1.2 caused dendrite retraction in mouse, rat and human neurons and identified a new signaling modality for the Ca V 1.2 channel. This sets the stage for studies aimed at understanding the underlying mechanism of ASD and intellectual disability in these children. In addition, these results unveil a mode of signaling for LTCs that is independent of Ca 2+ and directly links Ca V 1.2 channels to the regulation of RhoA signaling in the brain. a r t I C l e S METhODS Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
ONLINE METhODS dnA constructs. Ca V 1.2 constructs. Construction of the wild-type and dihydropyridine-resistant Ca V 1.2 (DHP) in the pcDNA4/HisMax vector has been previously described 36 . We generated plasmids encoding Ca V 1.2 N-terminally tagged with Flag and Myc epitopes as described previously using Gateway technology 51, 52 . We generated YH-Ca V 1.2 plasmids encoding Ca V 1.2 N-terminally tagged with YFP and containing an extracellular HA epitope tag in the S5-H5 loop of domain II as described previously 51 . Site-directed mutagenesis was performed with the QuickChange II XL kit (Stratagene) to generate the TS-Ca V 1.2, wild-type Ca V 1.2-3EQ, TS-Ca V 1.2-3EQ and TS-Ca V 1.2-4EQ mutant plasmids. The changed nucleotides were as follows: TS (G1216A), 3EQ (G1087C, G2116C and G3352C), 4EQ (G1087C, G2116C, G3352C and G4255C). Mutagenesis was always followed by full sequencing of the resulting channel. Primers and sequences are available upon request.
RhoA constructs. pcDNA3 Flag-RhoA V14A and pcDNA3 Flag-RhoA N19A were a generous gift from Y. Gotoh (University of Tokyo). The sequences encoding RhoA V14 and RhoA N19 were cut using BamHI and inserted into the pcDNA3-CFP vector to generate plasmids encoding either constitutively active (V14) RhoA or dominant-negative (N19) RhoA N-terminally tagged with CFP, which were then expressed in neurons. The pcDNA3-CFP vector was used as a control.
RGK constructs. The rat sequences encoding Gem (US National Center for Biotechnology Information (NCBI) reference sequence NM_001106637) or Rem2 (NM_022685) were cloned from cDNA prepared from mRNA isolated from rat embryonic day 18 (E18) cortex using the RNA Easy Kit (Qiagen). Plasmids encoding Myc-Gem or Myc-Rem2 were generated using Gateway technology (Invitrogen) by inserting the cloned rat Gem or Rem2 sequences into the TOPO sites of the pCR8 entry vector and then transferring the Gem-or Rem2-coding sequence into the destination vector pDEST Flag/Myc-, which contains a CMV promoter and N-terminal Flag and Myc eptiope tags in frame with ATTR acceptor sequences. A pDEST Flag-Myc CFP plasmid was generated in the same fashion (except CFP was cloned from the pcDNA3 CFP-plasmid) and was used as a control in all experiments using the pDEST Flag-Myc Gem or Rem2 plasmids. Site-directed mutagenesis was performed with the QuickChange II XL kit (Stratagene) to generate plasmids encoding the Gem R196A and Gem V223A mutants 25 . The following were changed in the Gem coding sequence of the pDest Flag/Myc Gem construct: Gem R196A (C586G and G587C), Gem V223A (T668C). All constructs and mutations were verified by full sequencing of the plasmids. All primers and sequences are available upon request.
RGK shRNA constructs. Two 19-mer oligonucleotide sequences targeted to the rat Gem sequence were designed using the Whitehead Institute Bioinformatics and Research Computing siRNA design tool 53 . Two 19-mer oligonucleotide sequences targeted to the rat Rem2 sequence were based on shRNA sequences that have been previously published 54 . The oligonucleotide sequences are as follows: Gem shRNA #1 (GATACATATGAGCGTACCC), Gem shRNA #2 (CCATTATCCTACTGGACAT), Rem2 shRNA#1(GAACTCAGAGGACACCT AT), Rem2 shRNA#2(GACGGATCATGGTGGACAA). Short hairpin oligonucleotides were designed (using Clontech's shRNA sequence designer) and inserted into RNAi-Ready pSIREN-DNR-DsRed-Express vector (Clontech) by ligation into the BamHI and EcoRI sites. For the control shRNA, a luciferase shRNA annealed oligonucleotide (Clontech, provided with pSIREN vector) was ligated into the pSIREN-DNR-DsRed-Express vector following the same procedure. To generate a plasmid encoding a Gem protein resistant to suppression by Gem shRNA #2, mutagenesis was performed as above on the pDEST Flag/Myc Gem construct. The three silent mutations were introduced into the Gem coding sequence with the following nucleotide changes: A384T, G387A and C390T. Mutations were verified by full sequencing and primers and sequences are available upon request.
co-immunoprecipitation and western blotting. To test effectiveness of shRNAs, HEK 293T cells grown in DMEM with 5% FBS were plated in 6-well plates and transfected by standard Ca 2+ phosphate procedures 36 . Each well of the 6-well plate was transfected with 2 µg shRNA, 100 ng pDEST Flag-Myc Gem, Flag-Myc Gem-R or Flag-Myc Rem2 and 100 ng of pDEST Flag-Myc CFP. Cells were lysed 36-48 h after transfection, and immunoblots were prepared as described previously 52 . Briefly, cells were lysed in 1× SDS buffer, lysates were boiled for 10 min at 100 °C, and 10 µl of lysates were run on a 10% polyacrylamide gel. Membranes were blotted with an anti-Myc antibody (1:1,000, 4-A6, Upstate Biotechnology). ImageJ (US National Institutes of Health) was used to quantify the intensity of the bands. The intensity of the RGK (Gem, Gem-R or Rem2) band was normalized to the intensity of the Myc-CFP band in the same lane, which was used as a transfection and loading control.
The Gem and β3 co-immunoprecipitation experiments were performed using HEK 293T cells grown in DMEM with 5% FBS and transfected by standard Ca 2+ phosphate procedures 36 . Each well of the 6-well plate was transfected with 1 µg pDEST Flag-Myc Gem, 1 µg HA-β3 or 1 µg of each alone. Cells were lysed 18-24 h after transfection with 300 µl lysis buffer (50 mM Tris pH 7.5, 100 mM NaCl, 1 mM MgCl 2 and 0.5% Triton X-100) per well. Protease inhibitor cocktail tablets (Roche Diagnostics) were added to lysis buffer immediately before lysing cells. Cell lysates were incubated for 1 h at 4 °C, centrifuged for 15 min to remove cell debris, and 250 µl of supernatant was incubated with 25 µl of anti-Flag M2 agarose beads (Sigma) for 3-4 h at 4 °C. Agarose beads were rinsed three times for 15 min each in lysis buffer, and then proteins were eluted with 50 µl of 1× SDS buffer, boiled for 8 min at 95 °C and frozen at −80 °C. Elutions were run on 10% polyacrylamide gels using standard western blot protocols and membranes were blotted with either anti-Myc antibody (1:1,000, 4A6, Upstate Biotechnology) or anti-HA 3F10 antibody (1:1,000, Roche).
The YFP-Ca V 1.2, Gem and β3 coimmunoprecipitation experiments were performed using Neuro2a cells grown in MEME with 10% FBS in 10-cm dishes and transfected using Lipofectamine 2000 (Invitrogen) following manufacturer's instructions. Each 10-cm plate was transfected with 6 µg pDEST Flag-Myc Gem, 6 µg HA-β3 and/or 12 µg of YFP-Cav1.2. Cells were lysed 22-24 h after transfection with 1 ml lysis buffer (50 mM Tris pH 7.5, 100 mM NaCl, 1 mM MgCl 2 , 1% Triton X-100) per plate. Protease inhibitor cocktail tablets (Roche Diagnostics) were added to lysis buffer immediately before lysing cells. Cells lysates were incubated for 1 h at 4 °C, centrifuged for 15 min to remove cell debris, and 900 µl of supernatant was incubated with 40 µl of anti-Flag M2 agarose beads (Sigma) for 3-4 h at 4 °C. Agarose beads were rinsed two times for 15 min each in lysis buffer, then one time for 15 min in 1× TBS and then proteins were eluted with 150 ng/µl 3× Flag peptide for 30 min at 4 °C. Supernatant was then mixed with 2× SDS sample buffer and boiled for 5 min at 85 °C. Elutions (10 µl of each) were run on 4-12% Bis-Tris gradient gels using standard western blot protocols and membranes were blotted with either anti-GFP rabbit serum (1:1,000, Invitrogen Molecular Probes), anti-Myc antibody (1:1,000, 4A6, Upstate Biotechnology) or anti-HA 3F10 antibody (1:1,000, Roche). dissociated cell cultures and transfections. Cortical neurons from E17-E19 Sprague Dawley rats (Rattus norvegicus) were cultured as described previously 55 and plated at 1 × 10 6 neurons/ml on poly-ornithine-and laminin-coated 24-or 96-well tissue culture plates. Neurons were maintained in Basal Medium Eagle with 5% FBS, 100 units/ml penicllin, 100 µg/ml streptomycin, 2 mM l-glutamine and 1% glucose. Neurons were transfected using Lipofectamine 2000 and assayed 30-48 h after transfection. For the dendritic arborization assay, Ca2 + imaging and phospho-MLC2 assay, neurons were transfected at 2-3 days in vitro (DIV) with a 2:2:0.5 ratio of α1c (pcDNA4 Ca V 1.2), β1b and YFP constructs. Molar ratios have been optimized so that the majority (>70%) of YFP-positive neurons also express the exogenous channel. For dendritic arborization assays using shRNAs targeting Gem, neurons were transfected at 2-3 DIV with a 2:0.5 ratio of pSIREN shRNA and pGW1 YFP, and imaged 48-72 h after transfection. The DsRed expression from the pSIREN construct was used to determine cotransfection efficiencies and >90% of cells expressing YFP also expressed the shRNA. For dendritic arborization assays involving RhoV14 or RhoN19 expression neurons were transfected with a 1:0.5 ratio of pcDNA3 CFP-RhoV14 (or pcDNA3 CFP-as control) and pGW1 YFP plasmids or with a 2:2:1:0.5 ratio of α1c (pcDNA4 CaV1.2): β1b: pcDNA3 CFP-RhoN19: YFP constructs. The same ratios were used for dendritic arborization assays involving Gem overexpression with pDest Flag/Myc CFP (control) or pDEST Flag/Myc Gem replacing the RhoN19 construct. For all experiments ratios were optimized so that the majority (>70%) of YFP-positive neurons also expressed the channel and other transfected constructs. dissociated culture immunocytochemistry. Dissociated cortical neurons were plated at 5 × 10 5 neurons/well on 15-mm cover slips placed in 24-well tissue culture plates. Thirty-six to forty-eight hours after transfection, neurons were fixed in 4% paraformaldehyde and 2% sucrose, permeabilized with 0.25% Triton X-100 and blocked in 3% BSA in phosphate-buffered saline (PBS). Neurons were incubated with anti-Myc antibodies (1:1,000, 4A6, Upstate Biotechnology) or npg anti-Ca V 1.2 antibodies (1:150, Chemicon AB5156) diluted in 3% BSA followed by incubation with Alexa Fluor 594-conjugated secondary antibodies (1:1,000, Invitrogen) and then counterstained with Hoechst 33258 (Molecular Probes, 1:10,000) for 15 min before mounting. YH-Ca V 1.2-expressing neurons were stained as outlined previously 51 . Briefly, neurons were fixed with 4% paraformaldehyde, blocked with 3% BSA, incubated with an anti-HA 3F10 antibody (1:1000, Roche 12158167001) and treated with a goat anti-rat Alexa Fluor 594 secondary antibody (1:1,000, Molecular Probes). Slides were visualized by epifluorescence microscopy using a cooled charge-coupled device (CCD) camera (Hamamatsu) coupled to an inverted Nikon Eclipse E2000-U microscope and OpenLab 4 software (Improvision).
Phospho-mlc2 assays. Twenty-four to thirty-six hours after transfection, neurons were placed in a control Tyrode's solution or depolarized in a 65 mM KCl Tyrode's solution for 1 h and then fixed with 4% paraformaldehyde in PBS for 10-15 min at room temperature. Neurons were then washed with 1× PBS two times and blocked in 3% BSA with 0.25% Triton X-100 in PBS for 30 min at room temperature. Neurons were then incubated with anti-phospho-myosin light chain 2 (Ser19) antibodies (1:1,000, Cell Signaling Technology) diluted in 3% BSA overnight at 4 °C. Neurons were then incubated with Alexa Fluor 594-conjugated secondary antibodies (1:1,000, Invitrogen) for 1 h and then counterstained with Hoescht 33258 (1:10,000) for 10 min before mounting cover slips on slides. Slides were visualized by epifluorescence microscopy using a cooled CCD camera (Hamamatsu) coupled to an inverted Nikon Eclipse E2000-U microscope and OpenLab 4 software (Improvision). The fluorescence intensity of phospho-MLC2 staining in YFP-positive neurons was quantified using OpenLab 4 software. At least 50 cells were quantified in each condition, and experiments were repeated at least three times. A histogram of intensity values in the control or stimulated conditions was used to determine a threshold value that separated pMLC2-positive cells from background staining. This value was used to quantify the percentage of cells in each condition that were pMLC2-positive. ca 2+ imaging. Cortical neurons were loaded with 1 mM Fura-2 acetoxymethyl ester (Invitrogen) for 30 min at 37 °C in cortical medium and placed in a specialized imaging chamber. Neurons were pre-incubated and imaged in Tyrode's solution (129 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 30 mM glucose, 25 mM Hepes and 0.1% BSA) for 100 ms followed by perfusion with a Tyrode's solution containing elevated potassium (75 mM NaCl, 67 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 30 mM glucose, 25 mM Hepes and 0.1% BSA). Imaging of selected transfected neurons (YFP-positive) was performed at 25 °C on an inverted epifluorescence microscope with cooled CCD camera and automated stage. Time-lapse excitation-ratio images were collected and quantified using OpenLab 4 software as described previously 36 . Values were converted to [Ca 2+ ] i using standard calibration procedures. Photostimulation. For experiments using light to stimulate cells electrically, dissociated hippocampal neurons were first infected with viruses carrying channelrhodopsin-2 (ChR2). Rat hippocampal neurons were obtained from E18 embryos as described 56 . Cells were plated on polyornithine/laminin-coated coverslips at low density (10 5 cells per well in 24-well plates) and cultured in Neurobasal medium supplemented with B27 and l-glutamine (all from Invitrogen). To produce viruses, 90% confluent HEK 293T cells (ATCC) cultured in 10-cm dishes were transfected with pLenti-CaMKII-hChR2 (H134R)-EYFP-WPRE 57 (Addgene plasmid 20944; (10 µg), VSVG (5 µg) and d8.2 (10 µg) using Lipofectamine 2000 reagent (Invitrogen) (30 µl)). After 15-20 h, medium was changed to neuronal culture medium, in which cells were kept for an additional 20-24 h. This conditioning medium containing viral particles was filtered and immediately used for neuronal transduction.
To perform photostimulation experiments, dissociated hippocampal neurons were initially cultured for 6-7 h in the conditioning medium containing viral particles. Under these experimental conditions, ~80-90% of neurons were fluorescent after 4 d in culture (DIC). At 3-4 DIC, neurons were transfected with plasmids encoding Ca V 1.2-or Ca V 1.2-TS, and YFP at a 1:1:0.1 ratio using Lipofectamine 2000. We optimized the number of days in culture, light intensity and the duration of light exposure to achieve reliable induction of action potentials in ChR2-expressing neurons without compromising survival. Photostimulation experiments were carried out 6 d after transfection (9 DIC) using a Zeiss Observer.Z1 microscope (Carl Zeiss) equipped with automated stage, X-Cite light source (EXFO) and ×10 objective. During each experiment, neurons were kept in modified Tyrode's solution (129 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 30 mM glucose, 25 mM HEPES, pH 7.4) supplemented with 2% B27 at 32-34 °C. All imaging experiments were performed using the Volocity software (Improvision). For image analysis, background correction was performed in Adobe Photoshop SC3 using the 'Levels' function so that the brightest and the darkest pixels had the same intensity in all the pictures.
To analyze dendritic arborizations in these experiments, we used the HCA-vision software (CSIRO), which performs a semiautomatic analysis of cell morphology. Parameters for dendrite detection, once set, were kept constant for all the pictures. Statistical analysis was done using Excel (Microsoft) and Prism 5 (GraphPad).
dendritic arborization assay and time-lapse imaging. Thirty-six to forty-eight hours after transfection, neurons were placed in a control Tyrode's solution or stimulated with Tyrode's solution containing 67 mM KCl and time-lapse images of cells were taken over a 9-h stimulation period at 10× magnification, using a highthroughput automated epi-fluorescence microscope with an environmentally controlled stage (ImageXpress, Molecular Devices). Imaging was performed on duplicate wells, with at least 20 images taken per well. Individual YFP-positive neurons were chosen in a blinded fashion such that the researcher was unaware of the treatment condition (well numbers were randomly recoded using an automated computer program). For each cell, dendrites were traced and measured at the 0 h and 9 h time points using ImageJ and NeuronJ programs 58 . The change in the number and length of primary dendrites and branch dendrites for each neuron was then measured and calculated. Similar methods were also used to perform time-lapse imaging analysis of neurons placed in a control Tyrode's solution or stimulated with Tyrode's solution containing 67 mM KCl, and imaged every 10 min over 60-80 min.
golgi staining of mouse brain and analysis of layer 2/3 dendritic arbors. Cacna1c + / tm2Itl mice (Mus musculus) containing the G406R mutation in exon 8A of the Cacna1c gene were generated as described previously 30 . Mice were backcrossed onto a C57BL/6J background and both male and female mice were used for all analyses. Golgi staining on brains from postnatal day 7 or 14 wild-type and Cacna1c + / tm2Itl littermate mice was performed using the Rapid GolgiStain Kit (FD Neurotechnologies) following the manufacturer's instructions. Briefly, brains from postnatal day 14 mice were removed and immersed in Golgi solution (solution A plus solution B) in the dark for 2 weeks. Brains were then cryoprotected for at least 48 h in solution C, sectioned at 150 µm thickness on a microtome, mounted onto gelatin-coated slides and developed following the manufacturer's protocol. Matched sections containing the frontal cortex were imaged using a ×20 objective and bright-field illumination on a Zeiss Axioimager M1 microscope with HRM digital camera system. Z-stacks were collected at ×20 across the width of the section and exported to Neurolucida software (MBF Biosciences) for analysis. The basal dendritic arbors of cortical layer 2/3 pyramidal neurons were reconstructed and measured using Neurolucida. All imaging and anaylsis was done blinded to the genotype of the mice. All experiments on mice or rats were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC) at Stanford University and following US National Institutes of Health guidelines for animal welfare. npg iPSc generation and neural differentiation. The iPSC clones were generated using retroviruses from fibroblasts harvested from two individuals with Timothy syndrome and two healthy subjects, as previously reported 33, 34 . Informed written consent was obtained from all human subjects used for this study. Two lines (clones) from one individual with Timothy syndrome (T7643-7 and T7643-32), one line from a second individual with Timothy syndrome (T9862-61) and three lines from two unaffected controls (NH2-6, IM23-16 and IM23-9) were differentiated into neurons and used for live imaging dendrite tracing. All the iPSC lines used in this study were extensively characterized previously 33, 34 . Neural differentiation of the pluripotent stem cells was performed as previously described 34 . Briefly, cellular aggregates were generated from iPSC colonies by enzymatic dissociation and kept in suspension for 5 d. For neural induction, the cellular aggregates were plated on a polyornithine/laminin-rich substrate. After 10 d, neural rosettes were mechanically isolated and expanded in suspension as neurospheres for an additional 7 d before the initiation of differentiation by replating, FGF2/EGF withdrawal and the addition of BDNF and NT3. The vast majority of neurons obtained with this protocol expressed cortical layer specific markers, as assessed by single cell quantitative PCR 34 .
tracing of dendrites in iPSc-derived neurons. Neuronal cultures, after 5 weeks of in vitro differentiation were infected with an adeno-associated virus (AAV5) carrying a YFP reporter gene under the control of the human Synapsin-1 promoter. Neurons expressing YFP under this promoter were imaged after 50-70 d of in vitro differentiation. For live imaging, neurons were grown on 15 mm glass coverslips (Warner Instruments) and placed in a perfusion chamber on the stage of confocal microscope (PerkinElmer) in a 5 mM KCl Tyrode solution containing 2% B27 (Invitrogen). After 30 min of imaging in a 5 mM KCl solution, a 67 mM KCl solution containing 2% B27 was injected in the chamber. Experiments were performed at ~30 °C. Total dendrite length of individual Synapsin-1-expressing neuron, before and after 2 h of depolarization, was traced semi-automatically using the HCA-Vision software (CSIRO). For assessing the number of retraction and extension events, cells were imaged every 5 min with a ×40 objective (Fig. 3d,f) .
